
ePT--the Electronic Newsletter of Pharmaceutical Technology
The US Food and Drug Administration appointed Frank M. Torti, M.D., M.P.H, as principal deputy commissioner and chief scientist. Torti's appointment with FDA will begin in May.

ePT--the Electronic Newsletter of Pharmaceutical Technology
The US Food and Drug Administration appointed Frank M. Torti, M.D., M.P.H, as principal deputy commissioner and chief scientist. Torti's appointment with FDA will begin in May.

ePT--the Electronic Newsletter of Pharmaceutical Technology
The US Food and Drug Administration issued a final guidance last week regarding investigational new drug applications for human gene therapy.

Equipment and Processing Report
A manufacturing line can be improved if technology transfer is implemented thoughtfully. Effective technology transfer helps to provide process efficiency and control and maintain product quality.

ePT--the Electronic Newsletter of Pharmaceutical Technology
MannKind suspended discussions with potential partners for the commercialization of its "Technosphere Insulin" product.

Equipment and Processing Report
This issue of Equipment & Processing Report features products from Leistritz and Millrock Technology

Equipment and Processing Report
Dave Drew, group pharmaceutical director of Matcon (Moreton-in-Marsh, UK), says that lean production is essential for drugmakers to survive in the current environment.

ePT--the Electronic Newsletter of Pharmaceutical Technology
Takeda Pharmaceutical agreed to acquire Millennium Pharmaceuticals for $8.8 billion in cash or $25 per share.

ePT--the Electronic Newsletter of Pharmaceutical Technology
Also, Alcon plans to open Singapore facility, Pharmacopeia president and CEO retired, more...

ePT--the Electronic Newsletter of Pharmaceutical Technology
Also, Jubilant Organosys to acquire DRAXIS Health, PPD's Paul Covington to retire, more...

ePT--the Electronic Newsletter of Pharmaceutical Technology
In an ongoing effort to secure the safety of prescription drugs, the US Food and Drug Administration has released its draft five-year plan under the Prescription Drug User Fee Act (PDUFA).

ePT--the Electronic Newsletter of Pharmaceutical Technology
Senator Chuck Grassley (R-IA) sent a letter to Amgen (Thousand Oaks, CA) last week asking the company to account for the high rebates it has given to certain physician groups who bought Aranesp.

ePT--the Electronic Newsletter of Pharmaceutical Technology
Combining atomic force microscopy and infrared spectroscopy, scientists at the University of Illinois have demonstrated a method for simultaneous structural and chemical characterization of samples at the femtogram (10-15g) level.

ePT--the Electronic Newsletter of Pharmaceutical Technology
Schering-Plough announced a major new productivity transformation program with a goal of achieving $1.5 billion in annual savings.

ePT--the Electronic Newsletter of Pharmaceutical Technology
The US Food and Drug Administration withdrew a direct final rule that changed current good manufacturing practice (CGMP) regulations for finished pharmaceuticals. The agency withdrew the rule because it received significant adverse comments from industry.

ePT--the Electronic Newsletter of Pharmaceutical Technology
The deadline for the implementation of California's prescription drug tracking system, ePedigree, has been delayed until January 2011.

ePT--the Electronic Newsletter of Pharmaceutical Technology
At its annual meeting, the Pharmaceutical Research and Manufacturers of America elected Richard T. Clark, CEO and president of Merck & Co., chairman of its board.

ePT--the Electronic Newsletter of Pharmaceutical Technology
One more step closer to finalization, the ISA 100 Wireless Compliance Institute presented a live demonstration of a prototype of the ISA 1001.11a wireless standard-based products at the 2008 Wireless Conference in Chongquing, China.

ePT--the Electronic Newsletter of Pharmaceutical Technology
US pharmaceutical and biotechnology research companies invested $58.8 billion in research and development in 2007, according to analyses by the Pharmaceutical Research and Manufacturers of America and Burrill & Company.

ePT--the Electronic Newsletter of Pharmaceutical Technology
Also, VaxGen and Raven terminate merger agreement, Darren Head appointed CEO of Cytovance, more...

ePT--the Electronic Newsletter of Pharmaceutical Technology
Filing risk and mitigation strategies is now a requirement for manufacturers of new drugs and biologics.

PTSM: Pharmaceutical Technology Sourcing and Management
The former formulation-development business of MDS Pharma Services seeks to build its niche in early-phase drug development.

A reference book omits important information and ignores advanced testing procedures.

Essential components of a good inspection: good ingredients, proper inserts, and ... deer?

A changing regulatory environment is on the horizon for excipient suppliers and users.

PTSM: Pharmaceutical Technology Sourcing and Management
Financial experts share their insights for the performance for innovator drug companies and generic-drug players.

Although there have been recent setbacks for China with regard to exported products, the country has made substantial strides in its pharmaceutical industry over the past few years. Intense competition and a series of new regulations seem to be moving the country into a period of recovery.

The FDA itself issues a cry for help. Is anybody listening?

Excipient producers and industry observers share their perspectives on innovation for excipients.

Antibodies are highly specific molecules that can be tailored to recognize almost any stretch of peptide that nature can conjure: a feature that has been exploited for years now to produce therapeutic antibodies.

Sophisticated replication techniques have made counterfeiting and fraud a serious threat to the pharmaceutical industry.